Aslan Gönül, Doruk Erdal, Emekdaş Gürol, Serin M Sami, Direkel Sahin, Bayram Gül, Durmaz Riza
Mikrobiyol Bul. 2007 Apr;41(2):185-92.
Genitourinary tuberculosis presents a challenge in diagnosis and treatment due to variations in clinical and radiological signs, insufficient patient history and difficulty in the isolation of the bacilli. The aim of this study was to isolate and identify Mycobacterium tuberculosis from the urine samples obtained from patients with suspected urinary tuberculosis admitted to our hospital by using Ehrlich-Ziehl-Neelsen (EZN), culture and polymerase chain reaction-restriction analysis (PCR-RFLP) methods. A total of 1004 urine samples collected from 437 patients who were admitted to our hospital between January 2004-July 2006, were inoculated on Löwenstein-Jensen (LJ) and/or BACTEC 12B (Becton Dickinson, USA) after decontamination and, direct preparations stained with EZN method were evaluated microscopically. M. tuberculosis complex (MTC) and mycobacteria other than tuberculosis (MOTT) were differentiated by nitro-alpha-acetylamino-beta-hydroxypropiophenone (NAP) test and the susceptibility testing for the MTC strains to primary antituberculosis drugs were performed by BACTEC 460 TB (Becton Dickinson, USA) system. PCR-RFLP method was performed for the identification of Mycobacterium spp. Twenty-two (5%) patients have yielded positive results by at least one of the conventional methods (EZN, LJ and/or BACTEC). Fifteen samples were positive for acido-resistant bacilli (ARB) by EZN method, and 17 samples were positive for mycobacterial growth in the cultures. Ten of 22 patients were found positive by both of the methods, while seven were culture positive but ARB negative and five were culture negative but ARB positive. These five patients received BCG treatment because of the presence of bladder tumor. Twelve (70.5%) of 17 strains isolated from culture were identified as MTC, while five (29.4%) were identified as M. fortuitum. Of 12 MTC isolates, eight (66.7%) were found susceptible to all of the antituberculosis agents, while one was found resistant to isoniazide (INH) and ethambutole (ETB), one was resistant to INH and rifampicin (RIF), and two were resistant to only INH. It is concluded that, in order to identify mycobacteria and to perform antituberculous susceptibility tests, cultivation of mycobacteria is a prerequisite.
由于临床和放射学体征存在差异、患者病史不充分以及结核杆菌分离困难,泌尿生殖系统结核病在诊断和治疗方面存在挑战。本研究的目的是通过使用埃利希-齐尔-尼尔森(EZN)法、培养法和聚合酶链反应-限制性分析(PCR-RFLP)法,从我院收治的疑似泌尿结核患者的尿液样本中分离并鉴定结核分枝杆菌。对2004年1月至2006年7月期间我院收治的437例患者收集的1004份尿液样本进行去污处理后,接种于罗-琴(LJ)培养基和/或BACTEC 12B培养基(美国贝克顿·迪金森公司),并对采用EZN法染色的直接涂片进行显微镜评估。通过硝基-α-乙酰氨基-β-羟基苯丙酮(NAP)试验区分结核分枝杆菌复合群(MTC)和非结核分枝杆菌(MOTT),并采用BACTEC 460 TB系统(美国贝克顿·迪金森公司)对MTC菌株进行一线抗结核药物敏感性检测。采用PCR-RFLP法鉴定分枝杆菌属。22例(5%)患者至少通过一种传统方法(EZN、LJ和/或BACTEC)获得阳性结果。EZN法检测到15份样本抗酸杆菌(ARB)阳性,培养法检测到17份样本分枝杆菌生长阳性。22例患者中有10例两种方法均为阳性,7例培养阳性但ARB阴性,5例培养阴性但ARB阳性。这5例患者因存在膀胱肿瘤接受了卡介苗治疗。从培养物中分离出的17株菌株中有12株(70.5%)被鉴定为MTC,5株(29.4%)被鉴定为偶然分枝杆菌。在12株MTC分离株中,8株(66.7%)对所有抗结核药物敏感,1株对异烟肼(INH)和乙胺丁醇(ETB)耐药,1株对INH和利福平(RIF)耐药,2株仅对INH耐药。得出的结论是,为了鉴定分枝杆菌并进行抗结核药敏试验,分枝杆菌培养是必要前提。